Urs Brändli
Chief Tech/Sci/R&D Officer at DOTTIKON ES HOLDING AG
Net worth: 1 M $ as of 30/03/2024
Profile
Urs Brändli is Head-Processes & Technologies at Dottikon Es Holding AG.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DOTTIKON ES HOLDING AG
0.03% | 30/03/2023 | 4,050 ( 0.03% ) | 1 M $ | 30/03/2024 |
Urs Brändli active positions
| Companies | Position | Start |
|---|---|---|
| DOTTIKON ES HOLDING AG | Chief Tech/Sci/R&D Officer | 31/12/2002 |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - |
| Dottikon Es Management AG | Corporate Officer/Principal | - |
Swiss Chemical Society
 Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DOTTIKON ES HOLDING AG | Process Industries |
| Private companies | 3 |
|---|---|
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Commercial Services |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
| Dottikon Es Management AG |
- Stock Market
- Insiders
- Urs Brändli
